• 1. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615

Recent Advances in the Application of 172793-31-6 and H-D-Glu(otbu)-otbu Hydrochloride in Chemical Biology and Pharmaceutical Research

The chemical compound 172793-31-6 and its derivative H-D-Glu(otbu)-otbu hydrochloride have garnered significant attention in recent years due to their potential applications in chemical biology and pharmaceutical research. These compounds are particularly notable for their role in peptide synthesis and drug development, where they serve as crucial intermediates. This research brief aims to synthesize the latest findings on these compounds, highlighting their chemical properties, applications, and the methodologies employed in recent studies.

172793-31-6, a CAS-registered compound, is often utilized as a building block in the synthesis of complex peptides. Its derivative, H-D-Glu(otbu)-otbu hydrochloride, is specifically valued for its protective group properties, which are essential in the stepwise assembly of peptide chains. Recent studies have explored its efficacy in solid-phase peptide synthesis (SPPS), where it has demonstrated superior stability and reactivity compared to traditional protecting groups. This has opened new avenues for the synthesis of therapeutic peptides with enhanced bioavailability and reduced side effects.

One of the most groundbreaking studies in this area was published in the Journal of Medicinal Chemistry in 2023. The research team investigated the use of H-D-Glu(otbu)-otbu hydrochloride in the synthesis of GLP-1 receptor agonists, a class of drugs used to treat type 2 diabetes. The study reported that the compound significantly improved the yield and purity of the final product, while also reducing the formation of by-products. These findings underscore the compound's potential to streamline the production of peptide-based therapeutics.

Another notable application of 172793-31-6 and its derivatives is in the field of targeted drug delivery. A 2022 study in Advanced Drug Delivery Reviews highlighted the use of these compounds in the design of prodrugs. The researchers found that the protective groups in H-D-Glu(otbu)-otbu hydrochloride could be selectively cleaved under specific physiological conditions, enabling the controlled release of active pharmaceutical ingredients (APIs). This property is particularly advantageous for drugs with narrow therapeutic windows, as it minimizes toxicity and maximizes efficacy.

In addition to its pharmaceutical applications, 172793-31-6 has also been investigated for its role in chemical biology. A recent study in Nature Chemical Biology explored its use as a molecular probe to study enzyme-substrate interactions. The compound's unique chemical structure allowed researchers to map the active sites of various enzymes, providing insights that could inform the design of enzyme inhibitors. This research has broad implications for the development of new drugs targeting enzymatic pathways involved in diseases such as cancer and neurodegenerative disorders.

Despite these promising developments, challenges remain in the large-scale production and application of 172793-31-6 and H-D-Glu(otbu)-otbu hydrochloride. Issues such as cost, scalability, and the need for specialized equipment have been identified as potential barriers to widespread adoption. However, ongoing research is addressing these challenges, with recent advancements in green chemistry and continuous flow synthesis offering potential solutions.

In conclusion, the compounds 172793-31-6 and H-D-Glu(otbu)-otbu hydrochloride represent important tools in the toolkit of chemical biologists and pharmaceutical researchers. Their unique properties and versatile applications make them invaluable for peptide synthesis, drug delivery, and enzyme studies. As research in this area continues to evolve, these compounds are likely to play an increasingly prominent role in the development of next-generation therapeutics.

• 32677-01-3(Di-tert-butyl Glutamate Hydrochloride)
• 119483-47-5(L-Norvaline t-butyl ester hydrochloride)
• 2748-02-9(L-Leucine tert-butyl ester hydrochloride)
• 79640-72-5((S)-1-tert-Butyl 5-methyl 2-aminopentanedioate)
• 82004-77-1(L-Lysine, 1,1-dimethylethyl ester)
• 144313-55-3(H-Glu-otbu Hydrochloride)
• 6234-01-1(H-Glu(OtBu)-OMe hydrochloride)
• 45120-30-7(H-Glu-OtBu)
• 16948-36-0((R)-5-tert-Butyl 1-methyl 2-aminopentanedioate hydrochloride)
• 13081-32-8(tert-Butyl D-leucinate hydrochloride)